Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2014Molecular TherapyOpen Access

Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAnat Globerson LevinTel Aviv UniversityTWTova WaksHarvard UniversityZEZelig EshharWeizmann Institute of Science

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Levin et al. (2014) studied this question.

synapsesocial.com/papers/6a7aa6a0756812e39589b1cbhttps://doi.org/10.1038/mt.2014.28
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression1997 · 114 citations
  2. 2The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors1999 · 452 citations
  3. 3A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth2012 · 53 citations
  4. 4Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.1998 · 159 citations